Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorambucil vs Fludarabine in Advanced Waldenström Macroglobulinemia
NCT00566332Phase 3Completed
- Sponsor
- French Innovative Leukemia Organization
- Start
- Jun 2001
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of fludarabine, chlorambucil in Waldenström macroglobulinemia (WM), Lymphoplasmacytic Lymphoma (LPL), splenic marginal zone lymphoma (SMZL), sponsored by French Innovative Leukemia Organization. Started Jun 2001; status: completed.
02
Drugs
fludarabinechlorambucil
03
Conditions
Waldenström macroglobulinemia (WM)Lymphoplasmacytic Lymphoma (LPL)splenic marginal zone lymphoma (SMZL)
Beyond the preview
Go deeper on NCT00566332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566332.